Starting
Initialising…
0%
BRCA2
Final classification
Likely Pathogenic
BRCA2 c.8375T>C · p.Leu2792Pro
BRCA2

The BRCA2 c.8375T>C (p.Leu2792Pro) variant has been reported in ClinVar, including a Likely Pathogenic expert-panel classification from ClinGen ENIGMA.

Gene
BRCA2
Transcript
NM_000059.3
HGVS · transcript:coding
NM_000059.3:c.8375T>C
Consequence
N/A
GRCh38
chr13:32370445 T>C
GRCh37
chr13:32944582 T>C
Basis ENIGMA BRCA1 and BRCA2 Specification v1.2 official final-classification framework was used, applying the Table 3 criteria-combination rules captured in final_classification_framework.
ENIGMA BRCA1 and BRCA2 Specification v1.2 official final-classification framework was used, applying the Table 3 criteria-combination rules captured in final_classification_framework.
Classification rationale
PS3PP3PP5 Likely Pathogenic
BRCA2 c.8375T>C

The BRCA2 c.8375T>C (p.Leu2792Pro) variant has been reported in ClinVar, including a Likely Pathogenic expert-panel classification from ClinGen ENIGMA.1 This variant is absent from gnomAD v2.1 and is present once in gnomAD v4.1 (1/1613924 alleles; AF 6.19608e-07), supporting rarity but not strict absence across available population datasets.2 In the ENIGMA BRCA2 curated functional dataset, two calibrated studies showed damaging protein function for this exact variant, and Table 9 assigns PS3 at strong strength.3 In silico data support a damaging protein effect within the BRCA2 DNA-binding domain, with BayesDel 0.54225 and REVEL 0.931, while SpliceAI predicts no significant splice impact (max delta 0.03).4

PS3 + PP3 + PP5 Likely Pathogenic
3 vcep_specifications_table9_v1_2_2024_11_18PMID:29884841 ↗cspec ↗
4 bayesdelrevelspliceai ↗cspec ↗
Gene diagram · NM_000059.3 · variants mapped to exon structure
BRCA2 NM_000059.3
Fetching transcript structure from UCSC…
Applied criteria · 3 met · select any tile
Met
Not met
Not assessed
N/A
Strength very strong supporting
Pathogenic evidence
PVS
PS
PM
PP
Benign evidence
BA
BS
BP
Rationale
Select a criterion.
Sources
Evidence used
    Gaps remaining
      Rule
      Research & evidence
      Population frequency · supports pathogenic
      gnomAD v4.1 screenshot
      gnomAD v4.1
      gnomAD v2.1 screenshot
      gnomAD v2.1
      v4.1
      This variant is present in gnomAD v4.1 (AF= 6.19608e-07; MAF= 0.00006%, 1/1613924 alleles, homozygotes = 0) and has highest observed frequency in the European (non-Finnish) population (AF= 8.47529e-07; MAF= 0.00008%, 1/1179900 alleles, homozygotes = 0).
      v2.1
      Absent from gnomAD v2.1.
      Allele frequency by ancestry
      three datasets · side by side
      gnomAD v4.1
      6.2e-05% · 1 / 1,613,924
      0 hom
      European (non-Finnish)
      1 / 1,179,900
      8.5e-05%
      + 9 not observed (Remaining individuals, Admixed American, European (Finnish), Amish, East Asian, Middle Eastern, South Asian, Ashkenazi Jewish, African/African American)
      gnomAD v2.1
      Absent · 0 / ?
      0 hom
      Not observed in any ancestry group.
      ClinVar screenshot
      ClinVar
      This variant has been reported in ClinVar as Likely pathogenic (3 clinical laboratories) and as Uncertain significance (2 clinical laboratories) and as Likely Pathogenic by ClinGen ENIGMA BRCA1 and BRCA2 Variant Curation Expert Panel, ClinGen (expert panel).
      SpliceAI screenshot
      In silico
      SpliceAI predicts no significant splice impact for this variant (max delta score = 0.03). REVEL score = 0.931. BayesDel score = 0.54225.
      Functional / OncoKB screenshot
      Functional Likely Oncogenic
      OncoKB identified variant-specific curated literature and context relevant to functional review; biological-effect context: Likely Loss-of-function; curated oncogenicity label: Likely Oncogenic.
      OncoKB ↗
      COSMIC screenshot
      COSMIC
      Cancer hotspots screenshot
      Cancer hotspots
      Somatic evidence Not in COSMIC / hotspots
      COSMIC
      This variant does not lie in a statistically significant hotspot. This variant has not previously been reported in somatic cancers (COSMIC).
      Hotspots
      This variant does not lie in a statistically significant hotspot.
      Literature · how each cited paper was used
      2papers cited
      Each card is an audit: what was searched, what was found, whether it names the variant, which criteria it fed, and why.
      PMID PMID:29884841
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      PMID PMID:32444794
      Found
      Structured finding pending for this record — see source link.
      Applied to
      PS3 supports · met
      Sources & reference links
      8Sources
      CSpec VCEP
      ClinVar
      gnomAD v2.1
      gnomAD v4.1
      SpliceAI
      OncoKB
      COSMIC
      Cancer hotspots